Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (22)

« Back to Publications

Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States.

Lui JNM. et al, (2023), J Am Heart Assoc, 12

zithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2021), Lancet, 397, 605 - 612

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.

Hopewell JC. et al, (2020), Eur Heart J, 41, 3336 - 3342

Cancer incidence in relation to body fatness among 0.5 million men and women: Findings from the China Kadoorie Biobank.

Wang L. et al, (2020), Int J Cancer, 146, 987 - 998

Investigating modifications to participant information materials to improve recruitment into a large randomized trial.

HPS2-THRIVE Collaborative Group . et al, (2019), Trials, 20

Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial.

Haynes R. et al, (2019), Clin Ther, 41, 1767 - 1777

Low pass genomes of 141,431 Chinese reveal patterns of viral infection, novel phenotypic associations, and the genetic history of China

Liu S. et al, (2019), EUROPEAN JOURNAL OF HUMAN GENETICS, 27, 803 - 804

Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.

ASCEND Study Collaborative Group . et al, (2018), N Engl J Med, 379, 1540 - 1550

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

ASCEND Study Collaborative Group . et al, (2018), N Engl J Med, 379, 1529 - 1539

SCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.

Bowman L. et al, (2018), Am Heart J, 198, 135 - 144

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.

HPS3/TIMI55–REVEAL Collaborative Group . et al, (2017), N Engl J Med, 377, 1217 - 1227

Telephone support for mail based recruitment and follow-up in a large randomized trial

Chen F. et al, (2017), TRIALS, 18

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.

REVEAL Collaborative Group . et al, (2017), Am Heart J, 187, 182 - 190

Folic acid supplementation with and without vitamin B6 and revascularization risk: a meta-analysis of randomized controlled trials.

Qin X. et al, (2014), Clin Nutr, 33, 603 - 612

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.

HPS2-THRIVE Collaborative Group ., (2013), Eur Heart J, 34, 1279 - 1291

Load More